Grace Therapeutics, Inc.
GRCE· Nasdaq
GRCEGrace Therapeutics, Inc.
Filed Aug 11, 2022 · 10-Q · 42 days after period end · 0000950170-22-016632
| Metric | Q1 2023 | Q1 2022 | Q1 2021 | Q1 2020 |
|---|---|---|---|---|
| Net Income | -$4.52M | -$3.12M | -$4.67M | -$8.85M |
| EPS Diluted | -$0.61 | -$0.12 | -$0.05 | -$0.11 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Grace Therapeutics, Inc. · CIK 1444192 · Engraved from SEC EDGAR
ended Jun 30, 2022 · filed Aug 11, 2022 · 42 d after period end
